Free Daily Headlines :

  • COVID-19
  • Vaccine Info
  • Money
  • Politics
  • Education
  • Health
  • Justice
  • More
    • Environment
    • Economic Development
    • Gaming
    • Investigations
    • Social Services
    • TRANSPORTATION
  • Opinion
    • CT Viewpoints
    • CT Artpoints
DONATE
Reflecting Connecticut’s Reality.
    COVID-19
    Vaccine Info
    Money
    Politics
    Education
    Health
    Justice
    More
    Environment
    Economic Development
    Gaming
    Investigations
    Social Services
    TRANSPORTATION
    Opinion
    CT Viewpoints
    CT Artpoints

LET�S GET SOCIAL

Show your love for great stories and out standing journalism

Connecticut receives its first, small, allotment of coronavirus-fighting remdesivir

  • Health
  • by Ana Radelat
  • May 11, 2020
  • View as "Clean Read" "Exit Clean Read"

A vial of remdesivir, manufactured by Gilead Sciences, Inc.

Washington – Under heat for its initial distribution of the only drug approved to fight coronavirus, federal officials have finally sent 30 cases of remdesivir to Connecticut.

Although Connecticut is a coronavirus “hot spot,” the state was not among those to receive the first shipments of the drug – other than vials sent for use in clinical trials.  The amount of drug the state is receiving will treat only a limited number of patients.

Produced by Gilead Sciences, Inc., remdesivir was recently approved by the Food and Drug Administration to be given to COVID-19 patients on an emergency basis, even though clinical trials of the drug, initially produced to combat Ebola, have not been completed on COVID-19 patients.

Remdesivir does not cure COVID-19, but has been found to shorten the average duration of infection, on average, from 14 to 11 days. The FDA set guidelines allowing remdesivir to be given to patients with  blood oxygen levels of 94% or lower, or otherwise requiring supplemental oxygen.

The Department of Health and Human Services was criticized last week for declining to specify which hospitals and states had received the first shipment of remdesivir for emergency use. On Saturday, HHS  confirmed that nearly 23,000 vials had initially been being shipped to New York, nearly 5,000 to Massachusetts, 4,000 to New Jersey, and smaller allotments to Indiana, Virginia, Rhode Island, and Tennessee.

It’s not clear which hospitals in Connecticut will receive the drug in the second shipment.  The Connecticut Department of Public Health, which has been tasked by HHS with distributing resdemivir in the state, would not comment.

“State health departments will distribute the doses to appropriate hospitals in their states because state and local health departments have the greatest insight into community-level needs in the COVID-19 response,” HHS said in a statement.

University of Connecticut’s  John Dempsey Hospital said it has received 32 doses of remdesivir and expects to treat three to five patients with it.

Trinity Health Of New England  said it received 160 vials of remdesivir this weekend through the Connecticut Hospital Association.  Trinity said the supply is specifically for its Connecticut hospitals — Saint Francis Hospital, Saint Mary’s Hospital, and Johnson Memorial Hospital.

“We have begun administering the medication to patients,” St. Francis Hospital spokesperson Kaitlin Rocheleau said.

Gilead says the suggested dose for adults and children who weigh at least 40 kilograms is 200 milligrams, or two vials, infused intravenously on Day 1 followed by once-daily maintenance doses of 100 milligrams, or one vial, infused for the next nine days.

Each case contains 40 vials of the drug, so the amount Connecticut has been allocated,  1,200 vials, will treat about 100 patients.

The HHS announcement made no mention of AmerisourceBergen, the drug distributor that had worked with Gilead last week to distribute remdesivir to hospitals.

Doctors and public health officials have called for the federal government to create a transparent system for distributing remdesivir.

Under the new plan, Connecticut was allotted 30 cases of the drug, Illinois 140 cases, Iowa 10 cases, Maryland 30 cases, Michigan 40 cases and New Jersey 110 cases.

Gilead says it will donate a total of 607,000 vials of remdesivir to treat roughly 78,000 patients in the next six weeks,  HHS said.

Sign up for CT Mirror's free daily news summary.

Free to Read. Not Free to Produce.

The Connecticut Mirror is a nonprofit newsroom. 90% of our revenue comes from people like you. If you value our reporting please consider making a donation. You'll enjoy reading CT Mirror even more knowing you helped make it happen.

YES, I'LL DONATE TODAY

ABOUT THE AUTHOR

Ana Radelat Ana has written about politics and policy in Washington, D.C.. for Gannett, Thompson Reuters and UPI. She was a special correspondent for the Miami Herald, and a regular contributor to The New York TImes, Advertising Age and several other publications. She has also worked in broadcast journalism, for CNN and several local NPR stations. She is a graduate of the University of Maryland School of Journalism.

SEE WHAT READERS SAID

RELATED STORIES
CT teachers are expected to get vaccinated for COVID at local clinics, but other options could cause problems
by Dave Altimari

School employees could end up on two lists, which means some vaccine might go to waste, officials said.

Black and Hispanic residents continue to be vaccinated against COVID at lower rates than white residents
by Kasturi Pananjady and Jenna Carlesso

Among those 65 and older, the rate of vaccination for white residents was 39%, compared to 21% for Black residents.

As mass vaccination centers take the lead in the COVID race, the push is on to reach the most vulnerable
by Dave Altimari

While mass vaccination sites have helped overall vaccination rates, they have not reached the state's most vulnerable populations.

Governor says frustrations with vaccine rollout should be with CDC guidelines
by Adria Watson

Lamont also said 30,000 doses of new J&J vaccine could arrive next week

Disability Rights CT files federal complaint over age-based vaccine rollout
by Kelan Lyons

The complaint alleges the state's age-based vaccine distribution plan discriminates against people with disabilities.

Support Our Work

Show your love for great stories and outstanding journalism.

$
Select One
  • Monthly
  • Yearly
  • Once
Artpoint painter
CT ViewpointsCT Artpoints
Opinion Lamont’s new vaccination priorities are simple and smart
by Richard Davies

Connecticut Gov. Ned Lamont’s new age-eligibility vaccine plan is simple, smart and straightforward. The more complicated the rules are, the greater the chance of screw-ups and of well-connected people getting their shots before they should. The governor is doing a good job.

Opinion Gas pipeline will threaten water quality, wildlife and wetlands
by Susan Eastwood

The Connecticut Department of Energy and Environmental Protection has granted tentative approval of the 401 water quality certification for the Pomfret to Killingly natural gas pipeline. I urge DEEP to deny the 401 certification, as the proposed pipeline would violate the Connecticut’s water quality standards, and the conditions in the draft certification fail to protect our streams, wetlands, and wildlife.

Opinion Connecticut and the other Connecticut. Which will endure?
by Ezra Kaprov

What comes to mind when you hear the word ‘Connecticut’? Possibly, you think of a 43-year-old Puerto Rican man who arrived here with his family following Hurricane Maria. He works full-time as a machinist at the Sikorsky plant, and he coaches a prizefighter on the side.

Opinion COVID-19 increases urgency for legislature to pass medical aid-in-dying law
by Dr. Gary Blick

The COVID-19 crisis has exposed the profound tragedy of loved ones dying alone, in a hospital or nursing home, without the care and comfort of loved ones surrounding them. This pandemic also demonstrates the fragility of life, the limits of modern medicine to relieve suffering, and has magnified the systemic racial disparities in our healthcare system, resulting in higher hospitalization and death rates for people in communities of color. We must eradicate these disparities, so everyone has equal access to the full range of end-of-life care options.

Artwork Grand guidance
by Anne:Gogh

In a world of systemic oppression aimed towards those of darker skintones – representation matters. We are more than our equity elusive environments, more than numbers in a prison and much more than victims of societal dispositions. This piece depicts a melanated young man draped in a cape ascending high above multiple forms of oppression. […]

Artwork Shea
by Anthony Valentine

Shea is a story about race and social inequalities that plague America. It is a narrative that prompts the question, “Do you know what it’s like to wake up in new skin?”

Artwork The Declaration of Human Rights
by Andres Chaparro

Through my artwork I strive to create an example of ideas that reflect my desire to raise social consciousness, and cultural awareness. Jazz music is the catalyst to all my work, and plays a major influence in each piece of work.”

Artwork ‘A thing of beauty. Destroy it forever’
by Richard DiCarlo | Derby

During times like these it’s often fun to revisit something familiar and approach things with a different slant. I have been taking some Pop culture and Art masterpieces and applying the vintage 1960’s and 70’s classic figures (Fisher Price, little people) to the make an amusing pieces. Here is my homage to Fisher -Price, Yellow […]

Twitter Feed
A Twitter List by CTMirror

Engage

  • Reflections Tickets & Sponsorships
  • Events
  • Donate
  • Newsletter Sign-Up
  • Submit to Viewpoints
  • Submit to ArtPoints
  • Economic Indicator Dashboard
  • Speaking Engagements
  • Commenting Guidelines
  • Legal Notices
  • Contact Us

About

  • About CT Mirror
  • Announcements
  • Board
  • Staff
  • Sponsors and Funders
  • Donors
  • Friends of CT Mirror
  • History
  • Financial
  • Policies
  • Strategic Plan

Opportunity

  • Advertising and Sponsorship
  • Speaking Engagements
  • Use of Photography
  • Work for Us

Go Deeper

  • Steady Habits Podcast
  • Economic Indicator Dashboard
  • Five Things

The Connecticut News Project, Inc. 1049 Asylum Avenue, Hartford, CT 06105. Phone: 860-218-6380

© Copyright 2021, The Connecticut News Project. All Rights Reserved. Website by Web Publisher PRO